Estimated Community Seroprevalence of SARS-CoV-2 Antibodies — Two Georgia Counties, April 28–May 3, 2020

Details

• Personal Author:
  Biggs, Holly M. ; Harris, Jennifer B. ; Breakwell, Lucy ; Dahlgren, F. Scott ; Abedi, Glen R. ; Szablewski, Christine M. ; Drobeniuc, Jan ; Bustamante, Nirma D. ; Almendares, Olivia ; Schnall, Amy H. ; Gilani, Zunera ; Smith, Tiffany ; Gieraltowski, Laura ; Johnson, Jeffrey A. ; Bajema, Kristina L. ; McDavid, Kelsey ; Schafer, Ilana J. ; Sullivan, Vickie ; Punkova, Lili ; Tejada-Strop, Alexandra ; Amiling, Raiza ; Mattison, Claire P. ; Cortese, Margaret M. ; Ford, S. Elizabeth ; Paxton, Lynn A. ; Drenzek, Cherie ; Tate, Jacqueline E.
• Corporate Authors:
  CDC Field Surveyor Team. ; CDC COVID-19 Response Team. ; Georgia. Department of Public Health. ; Centers for Disease Control and Prevention (U.S.)Epidemic Intelligence Service. ; DeKalb County (Ga.). Board of Health. ; Fulton County (Ga.). Board of Health.
• Description:
  What is already known about this topic? SARS-CoV-2 infection in persons who are asymptomatic or not tested might not be recognized by case-based and syndromic Surveillance; therefore, the population prevalence of past infection might be unknown.
  
  What is added by this report? A community seroprevalence survey, conducted in two counties in metropolitan Atlanta during April 28–May 3, using a two-stage cluster sampling design and serologic tTesting, estimated that 2.5% of the population had antibodies to SARS-CoV-2.
  
  What are the implications for public health practice? Serologic Surveillance can complement case-based and syndromic Surveillance. At the time of this survey, most of the two-county population had not been previously infected with SARS-CoV-2, highlighting the importance of continued mitigation measures to prevent infection, including social distancing, consistent and correct use of face coverings, and hand hygiene.
  
  Transmission of SARS-CoV-2, the Virus that causes coronaVirus disease 2019 (COVID-19), is ongoing in many communities throughout the United States Although case-based and syndromic Surveillance are critical for monitoring the pandemic, these systems rely on persons obtaining tTesting or reporting a COVID-19–like illness. Using serologic tests to detect the presence of SARS-CoV-2 antibodies is an adjunctive strategy that estimates the prevalence of past infection in a population. During April 28–May 3, 2020, coinciding with the end of a statewide shelter-in-place order, CDC and the Georgia Department of Public Health conducted a serologic survey in DeKalb and Fulton counties in metropolitan Atlanta to estimate SARS-CoV-2 seroprevalence in the population. A two-stage cluster sampling design was used to randomly select 30 census blocks in each county, with a target of seven participating households per census block. Weighted estimates were calculated to account for the probability of selection and adjusted for age group, sex, and race/ethnicity. A total of 394 households and 696 persons participated and had a serology result; 19 (2.7%) of 696 persons had SARS-CoV-2 antibodies detected. The estimated weighted seroprevalence across these two metropolitan Atlanta counties was 2.5% (95% confidence interval [CI] = 1.4–4.5). Non-Hispanic black participants more commonly had SARS-CoV-2 antibodies than did participants of other racial/ethnic groups (p<0.01). Among persons with SARS-CoV-2 antibodies, 13 (weighted % = 49.9; 95% CI = 24.4–75.5) reported a COVID-19–compatible illness,* six (weighted % = 28.2; 95% CI = 11.9–53.3) sought medical care for a COVID-19–compatible illness, and five (weighted % = 15.7; 95% CI = 5.1–39.4) had been tested for SARS-CoV-2 infection, demonstrating that many of these infections would not have been identified through case-based or syndromic Surveillance. The relatively low seroprevalence estimate in this report indicates that most persons in the catchment area had not been infected with SARS-CoV-2 at the time of the survey. Continued preventive measures, including social distancing, consistent and correct use of face coverings, and hand hygiene, remain critical in controlling community spread of SARS-CoV-2.
  
  Suggested citation for this article: Biggs HM, Harris JB, Breakwell L, et al. Estimated Community Seroprevalence of SARS-CoV-2 Antibodies — Two Georgia Counties, April 28–May 3, 2020. MMWR Morb Mortal Wkly Rep. ePub: 21 July 2020.
  
  mm6929e2.htm?s_cid=mm6929e2_w
  
  mm6929e2-H.pdf
  
  
• Content Notes:
  Case-based Surveillance -- Supplemental Surveillance -- Discussion -- Table 1 -- Table 2.
• Subjects:
  CoronaVirus Infection/Diagnosis Pneumonia, Viral/Diagnosis Seroepidemiologic Studies
• Source:
  MMWR: Morbidity and Mortality Weekly Report 2020; v. 69 Early Release
• Series:
  Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
• ISSN:
  0149-2195 (print) ; 1545-861X (digital)
• Document Type:
  Journal Article
• Place as Subject:
  Atlanta, GA ; Georgia
• Pages in Document:
  7 pdf pages
• Volume:
  69
• Collection(s):
  Morbidity and Mortality Weekly Report (MMWR)
• Main Document Checksum:
  urn:sha-512:73f8e90e08ba2e401f495387f3f2eb551fa073ff6a2b281594f9fcfe18d3832baba65d737ca2c1e2cde18a4b3d32792fd934ad7778dec5f80b5f5981648a768f
• Download URL:
  https://stacks.cdc.gov/view/cdc/90834/cdc_90834_DS1.pdf
• File Type:
  [PDF - 241.79 KB ]